Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

Park Ha Biological Technology Co., Ltd. (PHH)

Compare
11.79
-1.43
(-10.82%)
At close: April 1 at 4:00:01 PM EDT
11.85
+0.06
+(0.51%)
After hours: April 1 at 7:45:45 PM EDT
Loading Chart for PHH
  • Previous Close 13.22
  • Open 12.98
  • Bid 11.42 x 600
  • Ask 12.29 x 300
  • Day's Range 11.50 - 14.00
  • 52 Week Range 3.70 - 14.75
  • Volume 550,198
  • Avg. Volume 207,115
  • Market Cap (intraday) 310.954M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 589.50
  • EPS (TTM) 0.02
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

parkha.cn

17

Full Time Employees

October 31

Fiscal Year Ends

Recent News: PHH

View More

Performance Overview: PHH

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PHH
87.44%
S&P 500 (^GSPC)
4.23%

1-Year Return

PHH
187.56%
S&P 500 (^GSPC)
7.42%

3-Year Return

PHH
187.56%
S&P 500 (^GSPC)
23.92%

5-Year Return

PHH
187.56%
S&P 500 (^GSPC)
128.01%

Compare To: PHH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PHH

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    349.20M

  • Enterprise Value

    348.72M

  • Trailing P/E

    724.84

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    145.64

  • Price/Book (mrq)

    231.86

  • Enterprise Value/Revenue

    146.41

  • Enterprise Value/EBITDA

    427.14

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.09%

  • Return on Assets (ttm)

    18.55%

  • Return on Equity (ttm)

    38.00%

  • Revenue (ttm)

    2.38M

  • Net Income Avi to Common (ttm)

    478.56k

  • Diluted EPS (ttm)

    0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    547.5k

  • Total Debt/Equity (mrq)

    4.67%

  • Levered Free Cash Flow (ttm)

    -435.1k

Research Analysis: PHH

View More

Company Insights: PHH

Research Reports: PHH

View More

People Also Watch